Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by educational grants from Gilead Sciences, MacroGenics, Inc, and Puma Biotechnology, Inc.

School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

Release Date: February 22, 2021
Expiration Date: February 22, 2022

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in the treatment of breast cancer to provide a comprehensive overview of noteworthy data presented at the San Antonio Breast Cancer Symposium held virtually from San Antonio in December 2020. The School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio is an interactive program, in which the faculty discuss and debate the clinical implications and applications of these data and the future direction of breast cancer management. This webcast is an extension of the annual School of Breast Oncology®, and provides an additional forum for clinicians to keep pace with rapidly emerging data and advancing treatment paradigms in breast cancer.

This educational activity is an archive of the live virtual symposium held on February 3, 2021.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Gilead Sciences, MacroGenics, Inc, and Puma Biotechnology, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is directed toward medical oncologists who treat patients with breast cancer. Fellows, nurses, nurse practitioners, physician assistants, and other health care professionals involved in the management of breast cancer will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain the study design and primary end points of recent clinical trials evaluating novel strategies for the treatment of breast cancer
  • Assess the safety and efficacy profiles of novel and emerging therapeutic strategies that impact breast cancer management
  • Apply clinical trial evidence to the treatment paradigm across the breast cancer disease type and stage continuum

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Joyce O’Shaughnessy, MD
Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research,
Baylor University Medical Center
Chair, Breast Cancer Research Program
Texas Oncology
US Oncology Network
Dallas, TX

Disclosures: Consultant: AbbVie Inc, Agendia, Amgen, AstraZeneca, Bristol Myers Squibb, Celgene Corporation, Eisai, Eli Lilly and Company, Genentech, Genomic Health, GRAIL, Heron Therapeutics, Hoffmann-La Roche, Immunomedics, Ipsen Biopharmaceuticals, Jounce Therapeutics, Merck & Co, Inc, Myriad Pharmaceuticals, Novartis Pharmaceuticals, Odonate Therapeutics, Pfizer, Puma Biotechnology, Seattle Genetics, Syndax Pharmaceuticals.

Claudine Isaacs, MD
Claudine Isaacs, MD
Professor of Medicine and Oncology
Associate Director, Clinical Research
Co-Director, Breast Cancer Program
Medical Director, Fisher Center for Hereditary Cancer and Clinical Genomics Research
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

Disclosures: Grant/Research Support: Tesaro (to institution); Consultant: AstraZeneca, Eisai, Genentech, Novartis Pharmaceuticals Corporation, Puma Biotechnology, Seattle Genetics.

Terry P. Mamounas, MD, MPH, FACS
Terry P. Mamounas, MD, MPH, FACS
Professor of Surgery
University of Central Florida College of Medicine
Clinical Professor of Clinical Sciences
Florida State University College of Medicine
Medical Director, Comprehensive Breast Program
Orlando Health Cancer Institute
Orlando, FL

Disclosures: Consultant: Biotheranostics, Daiichi Sankyo, Exact Sciences, Genentech/Hoffmann-La Roche, Merck & Co., Puma Biotechnology; Speaker’s Bureau: Exact Sciences, Genentech/Hoffmann-La Roche.

The staff of Physicians’ Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By